Daily Archives

February 23, 2012

PrEP Could Be “Game Changer” in fight against HIV, Says Report from The Fenway Institute

By | HIV/AIDS, The Fenway Institute | No Comments
Analysis examines biomedical prevention technology to be reviewed by U.S. Food and Drug Administration by June 15, 2012 Pre-exposure chemoprophylaxis (PrEP) —taking antiretroviral medications to prevent HIV transmission—could be a “game changer” for HIV prevention, according to an analysis released by The Fenway Institute today. PrEP has demonstrated partial efficacy with men who have sex with men (MSM) and heterosexuals in several recent studies. Recent modeling of PrEP implementation coupled with scaled up treatment predicts that PrEP could significantly reduce HIV incidence and prevalence. If PrEP is accompanied by sustained care, behavioral interventions, and safety monitoring, PrEP need not lead 
Read More